Affiliation:
1. School of Basic Medical Sciences, Hubei University of Medicine, Shiyan, China
Abstract
Although artemisinin-based combination therapies (ACTs) have greatly improved the clinical outcome of cerebral malaria (CM) as a fatal disease that can permanently disable a significant proportion of children even if they survive, new treatment options are needed as
Plasmodium falciparum
develops resistance to antimalarial drugs. Recent reports suggest that basal treatment with artemisinin derivatives often fails to protect against cell death, neurological damage, and cognitive deficits.
Funder
The National Natural Science Foundation of China
The Principle Investigator Program of Hubei University of medicine
the Advantages Discipline Group (Public health) project in Higher Education of Hubei Province
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献